Although β2 microglobulin levels after chemotherapy were not statistically significant after multivariate logistic regression analysis, according to the literature (Wang et al. 2015), we believe that β2 microglobulin after chemotherapy is an independent predictor of the CR after treatment in gastric DLBCL patients. Here, HLA-G is linked to diffuse large B-cell lymphoma.